These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 14693737

  • 1. Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values.
    Endogenous Hormones and Breast Cancer Collaborative Group.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1457-61. PubMed ID: 14693737
    [Abstract] [Full Text] [Related]

  • 2. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882
    [Abstract] [Full Text] [Related]

  • 3. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations.
    Rinaldi S, Geay A, Déchaud H, Biessy C, Zeleniuch-Jacquotte A, Akhmedkhanov A, Shore RE, Riboli E, Toniolo P, Kaaks R.
    Cancer Epidemiol Biomarkers Prev; 2002 Oct 20; 11(10 Pt 1):1065-71. PubMed ID: 12376508
    [Abstract] [Full Text] [Related]

  • 4. Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations.
    Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug 20; 13(8):1296-301. PubMed ID: 15298949
    [Abstract] [Full Text] [Related]

  • 5. Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study.
    Chapurlat RD, Garnero P, Bréart G, Meunier PJ, Delmas PD.
    J Bone Miner Res; 2000 Sep 20; 15(9):1835-41. PubMed ID: 10977003
    [Abstract] [Full Text] [Related]

  • 6. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
    Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA, Schatzkin A.
    Cancer Epidemiol Biomarkers Prev; 1996 Jul 20; 5(7):533-9. PubMed ID: 8827358
    [Abstract] [Full Text] [Related]

  • 7. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):110-5. PubMed ID: 16418513
    [Abstract] [Full Text] [Related]

  • 8. Distribution of estradiol and percentage of free testosterone in sera of Japanese women: preoperative breast cancer patients and normal controls.
    Takatani O, Kosano H, Okumoto T, Akamatsu K, Tamakuma S, Hiraide H.
    J Natl Cancer Inst; 1987 Dec 18; 79(6):1199-204. PubMed ID: 3480371
    [Abstract] [Full Text] [Related]

  • 9. Assessment of the role of 17beta-oestradiol in bone metabolism in men: does the assay technique matter? The MINOS study.
    Szulc P, Claustrat B, Munoz F, Marchand F, Delmas PD.
    Clin Endocrinol (Oxf); 2004 Oct 18; 61(4):447-57. PubMed ID: 15473877
    [Abstract] [Full Text] [Related]

  • 10. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.
    J Natl Cancer Inst; 2005 May 18; 97(10):755-65. PubMed ID: 15900045
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1406-15. PubMed ID: 17018787
    [Abstract] [Full Text] [Related]

  • 14. A prospective study of estradiol and breast cancer in Japanese women.
    Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE.
    Cancer Epidemiol Biomarkers Prev; 2000 Jun 04; 9(6):575-9. PubMed ID: 10868691
    [Abstract] [Full Text] [Related]

  • 15. Reliability of measurements of total, protein-bound, and unbound estradiol in serum.
    Toniolo P, Koenig KL, Pasternack BS, Banerjee S, Rosenberg C, Shore RE, Strax P, Levitz M.
    Cancer Epidemiol Biomarkers Prev; 1994 Jun 04; 3(1):47-50. PubMed ID: 8118385
    [Abstract] [Full Text] [Related]

  • 16. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
    Schairer C, Hill D, Sturgeon SR, Fears T, Mies C, Ziegler RG, Hoover RN, Sherman ME.
    Cancer Epidemiol Biomarkers Prev; 2005 Jul 04; 14(7):1660-5. PubMed ID: 16030098
    [Abstract] [Full Text] [Related]

  • 17. Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions.
    Low YL, Taylor JI, Grace PB, Dowsett M, Scollen S, Dunning AM, Mulligan AA, Welch AA, Luben RN, Khaw KT, Day NE, Wareham NJ, Bingham SA.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan 04; 14(1):213-20. PubMed ID: 15668497
    [Abstract] [Full Text] [Related]

  • 18. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.
    J Natl Cancer Inst; 2004 Dec 15; 96(24):1856-65. PubMed ID: 15601642
    [Abstract] [Full Text] [Related]

  • 19. Assay reproducibility of hormone measurements in postmenopausal women.
    Falk RT, Dorgan JF, Kahle L, Potischman N, Longcope C.
    Cancer Epidemiol Biomarkers Prev; 1997 Jun 15; 6(6):429-32. PubMed ID: 9184776
    [Abstract] [Full Text] [Related]

  • 20. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS, Eliassen AH, Sluss P, Hankinson SE.
    J Clin Oncol; 2007 Apr 20; 25(12):1482-8. PubMed ID: 17372279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.